上期（总第228期）A股绿色周报显示，共有4家上市公司在近期暴露了环境风险。 每经AI快讯，"A股绿色报告"项目监控到的数据显示，恒瑞医药（600276）控股子公司福建盛迪医药有限公司福建盛迪高端原料药基地 二期建设项目环评审批获同意。该项目总投资额达2.5亿元。该审批信息于2025年12月26日被相关监管机构披露。 "A股绿色报告"项目由每日经济新闻联合环保领域知名NGO公众环境研究中心（IPE）共同推出，旨在让上市公司环境信息更加阳光透 明。本项目基于31个省（区、市）、337个地级市政府发布的权威环境监管数据，筛选监控上市公司及其旗下公司（包括分公司、参股 公司和控股公司）的环境表现，加以专业数据分析及深入解读，每日智能写作及时发布上市公司AI绿报，每周推出A股绿色周报，定期 动态更新上市公司环境风险榜。 (记者 刘志远 魏文艺) 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前核实。据此操作，风险自担。 ...

Group 1 - The Foshan Science and Technology Bureau has announced that Sanshui District Chanfang New Materials Technology Co., Ltd. will undertake the construction of a pilot base, which will be recognized as the "Foshan Chemical New Materials Pilot Base" [1] - This pilot base is the first recognized pilot platform in Foshan and the first public service-oriented chemical new materials pilot base in Guangdong Province [1] - The pilot base has an investment of 360 million yuan and is located in the core area of the Foshan (Sanshui) New Materials Industrial Park, which is part of the Greater Bay Area's extensive industrial space [1] Group 2 - The pilot base adopts an innovative operational model combining state-owned capital and private enterprises, forming a professional team with industry leaders to integrate technical expertise and industrial resources [1] - The pilot base focuses on electronic chemical products such as polishing liquids and photoresists, addressing the upstream material supply gap in the electronic information industry [1] - It aims to support the booming new energy vehicle industry by developing materials for new energy batteries and lightweight automotive components [1] Group 3 - The pilot base is also targeting the 100 billion yuan biopharmaceutical and health industry in Foshan, focusing on the development of high-end raw pharmaceuticals and pharmaceutical intermediates [1] - It plans to enhance traditional industries like textiles and furniture by creating new organic silicon and environmentally friendly dyeing additives [1] - The base is forward-looking in the field of future materials, working on special engineering plastics and biodegradable materials [1] Group 4 - In June, Foshan Jinyinhe Intelligent Equipment Co., Ltd. and Guangdong Chuanhua New Materials Co., Ltd. signed agreements with Sanshui Chanfang Group to establish pilot projects for solid-state batteries, rubidium-cesium salt purification, and dyeing additives [2]

Core Insights - Shandong Shanghe County focuses on industrial chain extension, supplementation, and strengthening, actively attracting and nurturing "chain leader" enterprises while promoting the integration of small and medium-sized enterprises into the industrial chain [1] Industry Summaries Biopharmaceutical and Chemical Industry - The biopharmaceutical and chemical industry in Shanghe County has seen significant growth, with 47 large-scale enterprises gathered, forming a collaborative development pattern centered on key pharmaceutical intermediates, high-end raw materials, and drug formulations, aiming for a target of 10 billion [1] Equipment Manufacturing Industry - The equipment manufacturing industry has achieved multiple breakthroughs, with 42 large-scale enterprises introduced, including Guangri Co., Ltd. and the Jinan Digital Industry Park, leading to the development of industries such as laser manufacturing and elevator manufacturing from inception to growth [1] Nutritional Food Industry - The nutritional food industry is taking shape, led by major enterprises like Sibote Biotechnology and Jinsah River Noodle Industry, establishing the Qilu Health Food Industrial Park and enhancing cold chain storage logistics, thereby accelerating the transformation of agricultural product resource advantages into industrial development advantages [1]

Core Viewpoint - The news highlights the strategic development of Jinan's industrial sector, particularly focusing on the "Industrial Strong City" initiative and the role of Shanghe County in enhancing industrial clusters and promoting a "chain-based" development model [1][3]. Group 1: Industrial Strategy and Development - Jinan's "Industrial Strong City" strategy aims for a significant upgrade in industrial capabilities by 2025, transitioning from "cluster development" to "chain-based breakthroughs" [1]. - Shanghe County is aligning its industrial development with Jinan's strategic goals, focusing on building a "chain-based" ecosystem that includes leading enterprises and small to medium-sized businesses [2][3]. Group 2: Key Industries and Clusters - The biopharmaceutical and chemical industries in Shanghe are developing a collaborative ecosystem, focusing on key pharmaceutical intermediates and high-end raw materials [2]. - Shanghe is establishing itself as a center for pharmaceuticals and high-end fine chemicals, contributing to Jinan's overall industrial strategy [3]. Group 3: Infrastructure and Service Innovations - Shanghe has introduced an innovative "park within a park" model to facilitate industrial clustering, providing specialized facilities tailored to different industry needs [4]. - The economic development zone in Shanghe is enhancing its infrastructure, including expanding steam supply capacity and wastewater treatment capabilities [4][6]. Group 4: New Production Capacity and Technological Advancements - Companies in Shanghe are focusing on digital transformation and smart manufacturing, with examples like Guangdian Elevator aiming to establish a digital factory [8]. - The region has nurtured specialized small and medium enterprises, contributing to the overall goal of transitioning from traditional manufacturing to intelligent manufacturing [9]. Group 5: Future Outlook and Goals - The year 2025 is pivotal for Jinan's industrial strategy, coinciding with the conclusion of the "Made in China 2025" initiative and the launch of new industrialization plans [9]. - Shanghe is committed to high-quality industrial development, aiming to contribute significantly to Jinan's industrial strength through innovation and strategic growth [9].

Core Insights - The event focused on the "Industrial Strong City Development Strategy" in Jinan, highlighting the efforts of Shanghe County in enhancing its industrial chain and attracting key enterprises [1] Industry Development - Shanghe County has concentrated on extending, supplementing, and strengthening its industrial chains, successfully attracting and nurturing "chain master" enterprises while facilitating the integration of small and medium-sized enterprises into these chains [1] - The biopharmaceutical and chemical industry has seen significant growth, with 47 large-scale enterprises established, focusing on key pharmaceutical intermediates, high-end raw materials, and drug formulations, aiming for a target of 10 billion [1] - The equipment manufacturing sector has achieved multiple breakthroughs, with 42 large-scale enterprises including Guangri Co., Ltd. and the Jinan Digital Industry Park, leading to the development of industries such as laser manufacturing and elevator manufacturing [1] - The nutritional food industry is beginning to take shape, led by major enterprises like Sibote Bio and Jinsha River Noodle Industry, with the establishment of the Qilu Health Food Industrial Park and improvements in cold chain logistics [1]

Core Viewpoint - The Jiangsu Wuxi Biopharmaceutical Industry Special Fund aims to promote the development of strategic emerging industries in Jiangsu Province, with a total scale of 4 billion yuan [1]. Group 1: Fund Structure and Investment Strategy - The fund is established in collaboration with Wuxi City to support the integration and development of strategic emerging industry clusters [1]. - Investment methods include setting up sub-funds or direct project investments, with direct investments generally not exceeding 30% of the actual investment amount of the special fund [1]. - The special fund's contribution to sub-funds will not exceed 30% of the sub-fund's total size, and investments in individual direct projects will not exceed 20% of the total paid-in capital of the special fund [1]. Group 2: Investment Focus Areas - The fund primarily invests in pharmaceuticals (including innovative drugs, high-end raw materials, traditional Chinese medicine, cell gene therapy, synthetic biology, etc.), medical devices (including in vitro diagnostic reagents and supporting instruments), and supportive medical industries (including research instruments, synthetic biology, CXO, new medical infrastructure, MAH platform companies, etc.) [2]. - Additional focus areas include consumer healthcare and improving national health quality (including health management, medical aesthetics, special medical foods, and functional foods), as well as AI in pharmaceuticals [2].